AKTX vs MRK: Valuation Comparison 2026
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Side-by-side fundamentals for Akari Therapeutics Plc (AKTX) and Merck & Co., Inc. (MRK) — market cap, PE, PEG and sector. All figures from SEC filings and market data.
| Metric | AKTX | MRK |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Current Price (Cboe, delayed) | $10.7 | $148.35 |
| Market Cap | $1.67T | $366.00B |
| PE Ratio | — | 116.81 |
| PEG Ratio | — | 5.60 |
| PEG Verdict | N/A | Potentially Overvalued |